Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

Quarter of all cancers found at late stage

November 15, 2010
Cancer, England, NCIN, NHS, National Cancer Intelligence Network, brain cancer, cancer diagnosis, leukaemia

Nearly a quarter of all cancer diagnoses in England came after a patient had been admitted to hospital for emergency …

News

NICE limits access to cancer drugs, study confirms

November 10, 2010
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Cancer Drugs Fund, IPSOR, Maximilian Lebmeier, NICE, hta

NICE became more restrictive in its assessment of new cancer drugs between 2007 and 2009, a new report suggests. The …

News

Roche’s melanoma candidate impresses in phase II trials

November 5, 2010
Research and Development BRAF protein, Cancer, Phase II, Plexxikon, RG7204, Roche

Roche’s mid-stage melanoma candidate has produced positive results in a difficult to treat cancer. RG7204 is an investigational, first-in-class molecule …

News

£600m confirmed for three year Cancer Drugs Fund

October 27, 2010
Sales and Marketing Cancer, Cancer Drugs Fund, NHS, NICE, cancer drugs, value-based pricing

The NHS will get the extra money it was promised to improve patient access to cancer medicines not backed by …

News

Cutting-edge cancer treatments showcased at ESMO

October 18, 2010
Research and Development AstraZeneca, Boehringer, Cancer, Cancer Conference, Johnson & Johnson, Novartis, personalised medicine

The search for a ‘silver bullet’ against cancer has failed, for now, with the battle against the disease turning instead …

Feature

Treasure trove of cancer information on tap for GPs

October 11, 2010
Medical Communications Cancer, Doctors.net.uk, GP, cancer care, online community, professional network

 Cancer Research UK appoints Doctors.net to launch campaign to raise awareness of the charity’s vast information resources for GPs

News
Press release

Uncertainty over new cancer fund

October 6, 2010
Sales and Marketing Cancer, NHS, government

The UK government has launched its £50 million interim fund to give greater access to new cancer medicines. The new …

News
ASCO

ASCO 2010: The Hedgehog Pathway and other ways to target cancer

August 19, 2010
Research and Development ASCO, Cancer, thyroid cancer

The American Society of Clinical Oncology conference, one of the most important dates in the pharmaceutical industry’s calendar, took place …

Feature

UK lags behind Europe on innovative cancer drugs

July 29, 2010
Sales and Marketing Cancer, market access

The UK has been ranked as one of the worst countries when it comes to uptake of new cancer drug …

News

Lansley to create £50 million cancer drugs fund

July 28, 2010
Sales and Marketing Cancer, NHS, government, market access

The UK government is setting up a multi-million pound fund dedicated to improving patient access to innovative new cancer drugs. …

News

New measures to help patients with mystery cancers

July 27, 2010
CUP, Cancer, NHS, NICE

Patients whose cancer has spread to other parts of the body from an unknown primary location are to be given …

News
Wellcome Trust Sanger Institute

Study boost for personalised cancer treatments

July 23, 2010
Research and Development Cancer, genome, genomics, personalised medicine

A five-year study by scientists in the UK and US of the way genomes and cancer medicines interact has yielded …

News

NICE rejects Takeda cancer drug over price concerns

July 12, 2010
Sales and Marketing Cancer, Mepact, NICE, Takeda, bone cancer

UK cost-effectiveness watchdog NICE has rejected Takeda’s orphan bone cancer drug Mepact due to concerns over price. In its draft …

News

Bayer signs cancer stem cell research deal

June 18, 2010
Research and Development Bayer Schering Pharma, Cancer, OncoMed, Stem cells

Bayer Schering Pharma has teamed up with a US oncology specialist to develop novel antibodies, protein therapeutics and small molecules …

News

Sanofi signs deal on pre-clinical cancer drugs

June 4, 2010
Research and Development Cancer, Sanofi

Sanofi-Aventis has signed a deal with US biotech company Ascenta to co-develop new oncology treatments aimed at restoring ‘apoptosis’ or …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026